Udforsk Servier
Servier, grundlagt i 1954, er den første selvstændige farmaceutiske gruppe. Vi har afdelinger i 149 lande med mere end 22.000 ansatte, hvoraf næsten 3.000 er indenfor forskning og udvikling
Coronavirus Information (COVID-19)
- 21/04/2020 - Covid-19: The Health Innovation Coalition selects its first digital projects!
- 20/04/2020 - Servier, committed to helping those who fight against the Covid-19
- 14/04/2020 - COVID-19: Servier China on the digital innovation front
- 06/04/2020 - Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline
- 02/04/2020 - World Autism Awareness Day: Servier is committed
- 25/03/2020 - Oncology: a first Marketing Authorization under its own name for Servier in Japan
- 25/03/2020 - Covid-19: Servier part of the Health Innovation Coalition in France
- 23/03/2020 - COVID-19: Beware of non-approved drugs and fake remedies!
- 23/03/2020 - The 2018/2019 annual report is out!
- 16/03/2020 - Cardiology: Servier awards its research fellowship to a young European researcher
- 13/03/2020 - Servier Greece awarded with the Top Employer certification
- 09/03/2020 - Blue March: Servier committed in the fight against colorectal cancer
- 09/03/2020 - Egis strengthens its partnership with Semmelweis University
- 06/03/2020 - Servier Italy awarded with the Top Employer certification
- 20/02/2020 - Servier presents its 2018/19 financial results and R&D pipeline
- Read more news